Glycemic variability may signal retinal changes
Greater glucose fluctuations but not HbA1c were associated with neuroretinal alterations over 3 years in pediatric patients with type 1 diabetes.
By
Andrea Surnit
September 1, 2026
Clinical Scorecard: Glycemic variability may signal retinal changes
At a Glance
Category Detail
Condition Type 1 Diabetes Key Mechanisms Glycemic variability and time in range affecting retinal layer thickness Target Population Pediatric patients aged 10 to 20 years with type 1 diabetes Care Setting Longitudinal study evaluating neuroretinal changes
Key Highlights
Glycemic variability associated with thinner retinal layers in type 1 diabetes patients Significant thinning of inner ganglion cell and outer plexiform layers over 3 years Greater time in range linked to thicker retinal layers No significant correlation between HbA1c levels and macular layer thickness Further longitudinal studies needed to assess predictive markers for diabetic neuropathy Guideline-Based Recommendations
Diagnosis
Assess retinal structure using spectral-domain optical coherence tomography (OCT) Evaluate glycemic variability using continuous glucose monitoring (CGM) Management
Maintain glycemic control with continuous subcutaneous insulin infusion Monitor time in range to support retinal health Monitoring & Follow-up
Conduct regular assessments of retinal layer thickness Perform peripheral and autonomic neurologic evaluations Risks
Higher glycemic variability may indicate risk for retinal neurodegeneration Potential for developing diabetic neuropathy Patient & Prescribing Data
Patients with type 1 diabetes, HbA1c < 9.5%, no diabetic retinopathy
Use of CGM and insulin infusion for at least 12 months
Clinical Best Practices
Regular monitoring of glycemic variability and time in range Incorporate retinal assessments in routine diabetes care Consider longitudinal evaluations for early detection of neuropathy Related Resources & Content
